Chronic Kidney Disease Complications 2

8 Feb 2025 5:30 p.m. 6:30 p.m.

Gangadhar Taduri Moderator

Time	Session

12 a.m. 12 a.m.	CINACALCET-INDUCED TORSADES DE POINTES IN A HAEMODIALYSIS PATIENT WCN25-AB-290, Poster Board= SAT-037	ALL CAUSE 5-YEAR MORTALITY IN PATIENTS INITIATED ON MAINTENANCE HEMODIALYSIS, A RETROSPECTIVE ANALYSIS WCN25-AB-1042, Poster Board= SAT-038	EFFICACY AND SAFETY OUTCOMES OF ANTI-TUBERCULAR TREATMENT IN CHRONIC KIDNEY PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. WCN25-AB-3711, Poster Board= SAT-039	ASSESSMENT OF PULMONARY FUNCTION THROUGH FORCED OSCILLATION TECHNIQUE (FOT) IN DIFFERENT STAGES OF CKD WCN25-AB-4014, Poster Board= SAT-040	PEGMOLESATIDE FOR THE TREATMENT OF ANEMIA IN NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: POST-HOC ANALYSIS OF A PHASE 3 TRIAL WCN25-AB-679, Poster Board= SAT-041	RADIONUCLIDE IMAGING OF THE PARATHYROID GLANDS TO PREDICT MEDICATION RESPONSE FOR HYPERPARATHYROIDISM IN CHRONIC KIDNEY DISEASE AND DIALYSIS WCN25-AB-1196, Poster Board= SAT-042	WHAT WE KNOW SO FAR ABOUT IRON OVERLOAD IN END-STAGE RENAL DISEASE? WCN25-AB-1150, Poster Board= SAT-043	MRI-BASED MEASUREMENT OF HEPATIC AND CARDIAC IRON OVERLOAD IN PATIENTS ON HEMODIALYSIS: A PROSPECTIVE COHORT STUDY WCN25-AB-1148, Poster Board= SAT-044	IS BILATERAL NEPHRECTOMY IN END-STAGE RENAL DISEASE PATIENTS WITH REFRACTORY HYPERTENSION A LOST ART? – A CASE SERIES WCN25-AB-1349, Poster Board= SAT-045	ORAL MANIFESTATIONS IN CHRONIC KIDNEY DISEASES(CKD) WCN25-AB-4537, Poster Board= SAT-046	EVALUATION OF CHANGES IN PULMONARY FUNCTION TESTS(PFT) WITH DECLINING EGFR IN CHRONIC KIDNEY DISEASE (CKD) ON CONSERVATIVE MANAGEMENT WCN25-AB-1417, Poster Board= SAT-047	BONE MINERAL DENSITY IN ELDERLY HIP FRACTURE PATIENTS: THE DUAL BURDEN OF TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE WCN25-AB-1476, Poster Board= SAT-048	KALABA CLAY : A CHEAPER TREATMENT OF HYPERKALIEMIA? WCN25-AB-1488, Poster Board= SAT-049	ASSESSMENT OF RENAL FUNCTION STATUS IN PATIENTS PRESENTING WITH MALIGNANCY AND ITS IMPACT ON PATIENT OUTCOMES WCN25-AB-4143, Poster Board= SAT-050	DEVELOPMENT AND EVALUATION OF CLINICAL RISK PREDICTION MODELS USING BONE TURNOVER MARKER FOR OSTEOPOROSIS SCREENING IN CHRONIC HEMODIALYSIS PATIENTS WCN25-AB-2671, Poster Board= SAT-051	A STUDY TO CORRELATE SERUM PHOSPHORUS WITH MARKER OF ENDOTHELIAL CELL DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS ON MAINTENANCE HAEMODIALYSIS. WCN25-AB-2130, Poster Board= SAT-052	THE EFFECT OF INTRAVENOUS FERRIC CARBOXYMALTOSE ON SERUM IFGF23 AND SERUM PHOSPHATE LEVELS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS WITH IRON INSUFFICIENCY: A PROSPECTIVE STUDY. WCN25-AB-1805, Poster Board= SAT-053	UTILITY OF SARC-F QUESTIONNAIRE IN IDENTIFYING SARCOPENIA IN CHRONIC KIDNEY DISEASE PATIENTS- A CROSS-SECTIONAL STUDY WCN25-AB-1998, Poster Board= SAT-054	DESIDUSTAT IN ERYHTROPOETIN INDUCED PURE RED CELL APLASIA IN DIALYSIS-DEPENDENT CKD PATIENTS: A CASE REPORT WCN25-AB-2158, Poster Board= SAT-055	REAL-WORLD EXPERIENCE OF DESIDUSTAT IN CKD PATIENTS WITH ANEMIA: A SINGLE CENTRE, OPEN LABEL, OBSERVATIONAL STUDY WCN25-AB-2135, Poster Board= SAT-056	REAL WORLD EXPERIENCE OF HIF-PHI – DESIDUSTAT (OXEMIA®) IN DIALYSIS AND NON-DIALYSIS DEPENDENT CKD ANEMIA PATIENTS WCN25-AB-2356, Poster Board= SAT-057	REAL-WORLD EXPERIENCE OF DESIDUSTAT IN CKD-ANEMIA PATIENTS: DATA FROM NORTHEAST INDIA WCN25-AB-2485, Poster Board= SAT-058	GENDER DIFFERENCES IN ALKALI REQUIREMENT FOR CORRECTING METABOLIC ACIDOSIS IN PREDIALYSIS CHRONIC KIDNEY DISEASE WCN25-AB-2348, Poster Board= SAT-059